This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Egenesis, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Angeles Albores: Inventor in Xenograft Research
Introduction
David Angeles Albores is an inventor based in Cambridge, Massachusetts. His work includes inventions concerning genetically modified cells, tissues, organs, and animals intended to improve xenograft survival and tolerance. He is associated with eGenesis, Inc., a company working in biotechnology.
Latest Patents
Albores is associated with 2 patents. His latest patent listings include “Cells, Tissues, Organs, and Animals Having One or More Modified Genes for Enhanced Xenograft Survival and Tolerance.” The disclosed subject matter concerns modified genes intended to enhance xenograft survival or tolerance, along with methods for making and using the modified biological materials.
Career Highlights
A key focus of Albores’s patent work is the genetic modification of biological materials for potential use in xenotransplantation. The inventions described address both the modified cells, tissues, organs, or animals and methods for their development and use.
Collaborations
Albores’s listed coworkers include Wenning Qin and Ranjith Anand. His work is associated with eGenesis, Inc.
Conclusion
David Angeles Albores’s patent activity centers on genetic modifications aimed at improving xenograft survival and tolerance, reflecting his contributions to biotechnology research at eGenesis, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile